Compare WNW & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WNW | VTGN |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 28.8M |
| IPO Year | 2020 | N/A |
| Metric | WNW | VTGN |
|---|---|---|
| Price | $1.49 | $0.74 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.90 |
| AVG Volume (30 Days) | 21.2K | ★ 6.2M |
| Earning Date | 05-12-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $2,550,178.00 | $721,000.00 |
| Revenue This Year | N/A | $54.26 |
| Revenue Next Year | N/A | $478.23 |
| P/E Ratio | $1.12 | ★ N/A |
| Revenue Growth | ★ 570.49 | N/A |
| 52 Week Low | $0.95 | $0.63 |
| 52 Week High | $70.00 | $5.14 |
| Indicator | WNW | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 24.89 |
| Support Level | $1.36 | $0.63 |
| Resistance Level | $1.48 | $0.71 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 56.79 | 32.67 |
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.